Dr. Hemnes is an Associate Professor of Medicine in the Division of Allergy, Pulmonary & Critical Care Medicine at the Vanderbilt University Medical Center. She is a renowned translational physician-scientist with a research focus on the role of altered metabolism in pulmonary vascular disease. Her interest in molecular phenotypes of pulmonary vascular disease has led to work demonstrating an Omic signature of vasodilator-responsive pulmonary arterial hypertension, which was one of the earliest publications demonstrating the feasibility of precision medicine in an ultra-rare pulmonary vascular disease. The Hemnes lab is now actively investigating novel blood-based Omic predictive strategies for FDA-approved therapies for pulmonary arterial hypertension. Dr. Hemnes also has clinical responsibilities which include managing patients in the Vanderbilt Center for Pulmonary Vascular Disease. She has effectively worked with this population to recruit into clinical studies for pulmonary vascular disease, including the treatment of pulmonary hypertension, diagnostic modalities in pulmonary vascular disease and novel classification of pulmonary vascular disease. She was recently appointed the new Editor in Chief of the journal Pulmonary Circulation.